Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer

Imprecision studies, interference testing and multicentre method comparison s using patient samples were carried out with of a new point-of-care test f or D-dimer (CARDIAC D-Dimer). The CV of the within-series and the day-to-da y imprecision with blood samples and control materials were between 7% and 13%. Compared with Tina-quant D-Dimer, CARDIAC D-Dimer showed a good correl ation and accuracy (n = 353; r = 0.92; y = 1.06x - 0.03), compared with STA LIATEST D-Dimer some poorer accuracy (n = 304; r = 0.91; y = 1.12x - 0.03) . No interference was detected for different hematocrit values (16% to 51%) and in investigations with hemoglobin (up to 0.13 mmol/l), biotin (up to 3 0 mug/l), bilirubin (up, to 330 mu mol/l), intralipid (up to 31.1 mmol/l) a nd rheumatic factor (up to 79 IU/ml). Overdosing or underdosing by 10 mul d id not affect the test result. The diagnostic sensitivity of CARDIAC D-Dime r for the detection of acute venous thromboembolic diseases was 100% in our study. With CARDIAC D-Dimer reliable quantitative D-dimer results can be e asily obtained. Because of the good analytical and clinical agreement with Tina-quant D-Dimer, it should be suitable for ruling out venous thromboembo lic diseases. (C) 2001 Elsevier Science B.V. All rights reserved.